14-day Premium Trial Subscription Try For FreeGet Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of CASI
Powered by GPT-4
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Friday for CASI Pharmaceuticals
(Updated on Dec 01, 2023)

Buy or Hold candidate since Sep 27, 2023 Gain 143.04% PDF
No changes to the price of CASI Pharmaceuticals stock on the last trading day (Friday, 1st Dec 2023). During the last trading day the stock fluctuated 5.57% from a day low at $5.38 to a day high of $5.68. The price has risen in 6 of the last 10 days and is up by 25.06% over the past 2 weeks.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 163.85% during the next 3 months and, with a 90% probability hold a price between $12.25 and $16.25 at the end of this 3-month period.

CASI Signals & Forecast

The CASI Pharmaceuticals stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $5.41 and $4.25. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Friday, November 24, 2023, and so far it has fallen -4.44%. Further fall is indicated until a new bottom pivot has been found. Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point".

Get your hands on a piece of history – invest in multi-million dollar paintings from $10k with Masterworks.

Support, Risk & Stop-loss for CASI Pharmaceuticals stock

On the downside, the stock finds support just below today's level from accumulated volume at $5.20 and $4.86. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, CASI Pharmaceuticals finds support just below today's level at $5.20. If this is broken, then the next support from accumulated volume will be at $4.86 and $4.72.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.300 between high and low, or 5.57%. For the last week the stock has had daily average volatility of 10.16%.

Our recommended stop-loss: $5.31 (-4.99%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 5 days ago.)

Trading Expectations (CASI) For The Upcoming Trading Day Of Monday 4th

For the upcoming trading day on Monday, 4th we expect CASI Pharmaceuticals to open at $5.55, and during the day (based on 14 day Average True Range), to move between $5.10 and $6.08, which gives a possible trading interval of +/-$0.486 (+/-8.70%) up or down from last closing price. If CASI Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 17.39% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $5.60 (0.18%) than the support at $5.20 (6.98%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is CASI Pharmaceuticals stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for CASI Pharmaceuticals stock to perform well in the short-term.

Current score: 2.687 Open Broker Account

Buy Candidate Unchanged

Predicted Opening Price for CASI Pharmaceuticals of Monday, December 4, 2023

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Fair opening price December 4, 2023 Current price
$5.55 $5.59 (Overvalued)

Remember To Visit Our YouTube Channel

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 5.85 4.65 %
R2 5.74 2.60 %
R1 5.66 1.33 %
Current price: 5.59
Support S1 5.44 -2.76 %
S2 5.36 -4.03 %
S3 5.25 -6.08 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 5.85 4.65 %
R2 5.70 1.97 %
R1 5.60 0.179 %
Current price 5.59
Support S1 5.20 -6.98%
S2 4.86 -13.06%
S3 4.72 -15.56%
What is the symbol for CASI Pharmaceuticals Stock and on which exchange is it traded?
The symbol for CASI Pharmaceuticals is CASI and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell CASI Pharmaceuticals Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for CASI Pharmaceuticals stock to perform well in the short-term.

How to buy CASI Pharmaceuticals Stock?
CASI Pharmaceuticals Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy CASI Pharmaceuticals Stock.

What's the current price of CASI Pharmaceuticals Stock?
As of the end of day on the 2023-12-01, the price of an CASI Pharmaceuticals (CASI) share was $5.59.

What is the 52-week high and low for CASI Pharmaceuticals Stock?
The 52-week high for CASI Pharmaceuticals Stock is $5.94 and the 52-week low is $1.45.

What is the market capitalization of CASI Pharmaceuticals Stock?
As of the 2023-12-01, the market capitalization of CASI Pharmaceuticals is 74.467M.

Click to get the best stock tips daily for free!

About CASI Pharmaceuticals

CASI Pharmaceuticals CASI Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapeutics and pharmaceutical products in China, the United States, and internationally. It offers EVOMELA, an intravenous formulation of melphalan for use as a conditioning treatment prior to stem cell transplantation, and as a palliative treatment for patients with multiple myeloma. The company's product pipeline includes CNCT19, an autologous CD19 CAR-T inve... CASI Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE